Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
1.
Sci Rep ; 11(1): 8588, 2021 04 21.
Article in English | MEDLINE | ID: mdl-33883587

ABSTRACT

This nationwide population-based cohort study aimed to investigate the impact of systemic anti-inflammatory treatment on the major adverse cardiovascular events (MACE) risk in patients with psoriasis from January 2006 to December 2018, using a database provided by the Korean National Health Insurance Service. Patients were grouped based on the following treatment modalities: biologics, phototherapy, methotrexate, cyclosporine, and mixed conventional systemic agents. Patients who had not received any systemic treatment were assigned to the control cohort. The incidence of MACE per 1000 person-year was 3.5, 9.3, 12.1, 28.4, 39.5, and 14.5 in the biologic, phototherapy, methotrexate, cyclosporine, mixed conventional systemic agents, and control cohorts, respectively. During the 36-month follow-up, the cumulative incidence of MACE in the phototherapy and biologic cohorts remained lower than that of other treatment modalities. Cyclosporine (hazard ratio (HR) = 2.11, 95% confidence interval (CI) = 1.64-2.71) and mixed conventional systemic agents (HR = 2.57, 95% CI = 2.05-3.22) treatments were associated with increased MACE risk. Methotrexate treatment was not associated with MACE. Our finding demonstrates that treatment modalities may affect cardiovascular comorbidities in patients with psoriasis. Thus, an appropriate combination of anti-psoriatic therapies should be considered to manage patients with high cardiovascular risk.IRB approval status: Waiver decision was obtained by the institutional review board, Konkuk University Hospital, Seoul, Republic of Korea (KUH1120107).


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cardiovascular Diseases/epidemiology , Psoriasis/drug therapy , Acitretin/therapeutic use , Adult , Aged , Cyclosporine/therapeutic use , Female , Humans , Incidence , Male , Methotrexate/therapeutic use , Middle Aged , Phototherapy , Proportional Hazards Models , Republic of Korea/epidemiology , Severity of Illness Index , Young Adult
2.
Eur J Dermatol ; 2020 Apr 16.
Article in English | MEDLINE | ID: mdl-32301723

ABSTRACT

BACKGROUND: Psoriasis is an immune-mediated inflammatory disease in which imbalance of the immunological response may be associated with disease severity and comorbidities. Latent tuberculosis infection (LTBI) is a growing concern for treatment of psoriasis, as the use of biologics has recently increased. OBJECTIVES: To investigate the clinical and immunological influence of LTBI on the features of psoriasis. MATERIALS AND METHODS: We conducted a retrospective analysis of 300 patients with psoriasis using clinical information, including severity, comorbidities, and presence of LTBI. Serum cytokine levels were measured for immunological analysis. RESULTS: The prevalence of psoriatic arthritis (p = 0.001) and nail psoriasis (p = 0.014) in patients with LTBI was significantly higher than in those without LTBI, although other data including the Psoriasis Area Severity Index showed no association. The serum levels of interleukin (IL)-6, IL-8, and IL-23A in the LTBI-positive group were higher than those in the LTBI-negative group (p = 0.014, p = 0.025, and p = 0.004, respectively). CONCLUSION: LTBI may be a risk factor for the development of psoriatic arthritis during chronic inflammatory conditions induced by tuberculosis infection.

3.
Mycoses ; 63(3): 314-322, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31834952

ABSTRACT

Impaired immunity and changes in the microenvironment in patients with diabetes might influence the composition of the cutaneous microbiome. However, data on the cutaneous microbiome of these patients are scarce. This study compared the fungal and bacterial components of the skin microbiome between patients with type 2 diabetes mellitus (DM) and healthy individuals. We obtained skin swab samples from the plantar forefoot of 17 patients with DM and 18 healthy individuals to conduct a cross-sectional study. The samples were profiled with culture-independent sequencing of the V3 to V4 regions of the bacterial 16S rRNA gene and the fungal ITS2 region, followed by direct DNA extraction and molecular polymerase chain reaction (PCR). We observed a differential cutaneous microbiome, especially for fungi, in patients with type 2 diabetes compared to that in healthy controls. Trichophyton rubrum was more abundant in DM samples. The Shannon diversity index for fungi was lower in the DM patients. Principal coordinate analysis plots and permutational multivariate analysis of variance (PERMANOVA) tests based on Bray-Curtis distances between samples supported the association of the fungal microbiome with DM at the species level. The results suggest that clinicians should pay attention to both fungi and bacteria and provide appropriate prevention and therapeutic strategies for diabetic cutaneous complications including diabetic foot ulcers. These data also contribute to future research associated with diabetes and cutaneous microbiomes.


Subject(s)
Bacteria/classification , Diabetes Mellitus, Type 2/microbiology , Foot/microbiology , Fungi/classification , Microbiota , Skin/microbiology , Aged , Biomarkers , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Male , Middle Aged
4.
Sci Rep ; 9(1): 18921, 2019 12 12.
Article in English | MEDLINE | ID: mdl-31831764

ABSTRACT

Interleukin 17 (IL-17) plays pivotal role in the pathogenesis of psoriasis. In a previous study, we identified a locus in the IL17F gene that is associated with psoriasis, the IL17F rs763780 (His161Arg) T/C variant. The current study aimed to elucidate the association between this polymorphism and psoriasis, and to determine its effect on serum levels of cytokine. A total of 116 psoriasis patients and 97 healthy volunteers were recruited. Genotyping analysis was performed using quantitative polymerase chain reaction, and serum levels of cytokine were measured using a multiplex immunoassay. The IL17F His161Arg polymorphism was significantly associated with psoriasis based on the genotype and allele analyses. Psoriasis patients harbouring the mutant allele had significantly increased serum levels of IL-17F. Our results suggest that this polymorphism is a potential risk locus for psoriasis and that it results in a direct increase in IL-17F production.


Subject(s)
Genetic Loci , Interleukin-17 , Mutation, Missense , Polymorphism, Genetic , Psoriasis , Adolescent , Adult , Aged , Amino Acid Substitution , Asian People , Female , Humans , Interleukin-17/blood , Interleukin-17/genetics , Male , Middle Aged , Psoriasis/blood , Psoriasis/genetics , Risk Factors
5.
Dermatol Surg ; 45(9): 1155-1162, 2019 09.
Article in English | MEDLINE | ID: mdl-30730346

ABSTRACT

BACKGROUND: Botulinum toxin (BTX) has been used cosmetically with good clinical efficacy and tolerable safety. OBJECTIVE: This randomized, double-blind, split-face clinical study aimed to investigate the efficacy and safety of intradermal BTX in patients with rosacea. MATERIALS AND METHODS: Twenty-four participants were enrolled and randomly given intradermal injections of BTX and normal saline in both cheeks. Clinician Erythema Assessment (CEA) score, Global Aesthetic Improvement Scale (GAIS) score, skin hydration, transepidermal water loss (TEWL), melanin content, erythema index, elasticity, and sebum secretions were evaluated at baseline and 2, 4, 8, and 12 weeks. RESULTS: On the BTX-treated side, the CEA score significantly decreased and the GAIS score significantly increased. The erythema index decreased at Weeks 4 and 8. Skin elasticity was improved at Weeks 2 and 4 and skin hydration, at Weeks 2, 4, and 8. However, TEWL and sebum secretion did not show significant differences. CONCLUSION: Intradermal BTX injections reduced erythema and rejuvenated the skin effectively and safely in patients with rosacea.


Subject(s)
Botulinum Toxins, Type A/administration & dosage , Erythema/drug therapy , Erythema/physiopathology , Facial Dermatoses/drug therapy , Facial Dermatoses/physiopathology , Neuromuscular Agents/administration & dosage , Rosacea/drug therapy , Rosacea/physiopathology , Adult , Botulinum Toxins, Type A/adverse effects , Double-Blind Method , Elasticity , Esthetics , Female , Humans , Injections, Intradermal , Male , Middle Aged , Neuromuscular Agents/adverse effects , Pilot Projects , Rejuvenation , Sebum/metabolism , Skin/physiopathology
6.
J Microbiol Biotechnol ; 29(2): 321-329, 2019 Feb 28.
Article in English | MEDLINE | ID: mdl-30609881

ABSTRACT

Hair loss, also known as alopecia, is a common dermatological condition of psychosocial significance; development of therapeutic candidates for the treatment of this condition is, hence, important. Silibinin, a secondary metabolite from Silybum marianum, is an effective antioxidant that also prevents various cutaneous problems. In this study, we have investigated the effect of silibinin on hair induction using three-dimensional (3D) cultured, human dermal papilla (DP) spheroids. Silibinin was found to significantly increase viability through AKT serine/threonine kinase (AKT) activation in 3D DP spheroids. This was correlated with an increase in the diameter of the 3D DP spheroids. The activation of the wingless and INT-1 (Wnt)/ß-catenin signaling pathway, which is associated with hair growth induction in the DP, was evaluated using the T cell-specific transcription factor and lymphoid enhancer-binding factor (TCF/LEF) transcription factor reporter assay; results indicated significantly increased luciferase activity. In addition, we were able to demonstrate increased expression of the target genes, WNT5a and LEF1, using quantitative real-time PCR assay. Lastly, significantly elevated expression of signature genes associated with hair induction was demonstrated in the 3D DP spheroids treated with silibinin. These results suggest that silibinin promotes proliferation and hair induction through the AKT and Wnt/ß-catenin signaling pathways in 3D DP spheroids. Silibinin can be a potential candidate to promote hair proliferation.


Subject(s)
Antioxidants/pharmacology , Dermis/drug effects , Hair Follicle/drug effects , Hair Follicle/growth & development , Proto-Oncogene Proteins c-akt/metabolism , Silybin/pharmacology , Wnt Signaling Pathway/drug effects , Cell Survival/drug effects , Cells, Cultured , Dermis/cytology , Dermis/growth & development , Dermis/metabolism , Gene Expression Regulation/drug effects , Hair Follicle/cytology , Hair Follicle/metabolism , Humans , Lymphoid Enhancer-Binding Factor 1/genetics , Phosphorylation , Spheroids, Cellular/cytology , Spheroids, Cellular/drug effects , Wnt-5a Protein/genetics
7.
Ann Dermatol ; 31(4): 420-425, 2019 Aug.
Article in English | MEDLINE | ID: mdl-33911620

ABSTRACT

BACKGROUND: Although oral antihistamines (H1-histamine receptor antagonists) are the main treatment option for pruritus in general skin dermatosis, their effect in treating pruritus of atopic dermatitis (AD) has not yet been established. OBJECTIVE: We conducted a systematic review and meta-analysis to evaluate the effectiveness of combined therapy of H1-antihistamines and topical steroids. METHODS: We systematically searched MEDLINE, Embase, and CENTRAL databases for articles published from 1967 to 2015. We identified 1,206 studies and assessed their titles, abstract, and full-text. Random effects meta-analysis was used to calculate mean differences (MD) with 95% confidence intervals (CI). RESULTS: Two studies satisfying the inclusion criteria of antihistamine therapy with mandatory topical steroid use were selected. Comparing antihistamine monotherapy with combination therapy, patients treated with the addition of antihistamine to topical corticosteroids showed a statistically significant clinical improvement (standard MD, -0.24; 95% CI, -0.42 to -0.05; p=0.01). CONCLUSION: H1-antihistamines may have a synergistic effect when combined with topical steroids by influencing various associative factors of chronic pruritus in AD.

8.
Ann Dermatol ; 30(3): 296-303, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29853743

ABSTRACT

BACKGROUND: Over the past 10 years, monopolar radiofrequency (MRF) technology has been widely used by dermatologists as a valuable modality to effectively tighten and rejuvenate photoaged skin. It also has the benefit of a short recovery time. OBJECTIVE: Using an objective parameter, this study aimed to assess the efficacy and safety of MRF, which is the basic modality of radiofrequency technologies, for treatment of periorbital wrinkles in Korean patients. METHODS: We enrolled 70 middle-aged female patients with periorbital wrinkles for this study. Each patient underwent triple sessions of MRF treatment in the periorbital region, separated by 2-week intervals. Clinical photographs were obtained, and the areas of wrinkles were measured using a Robo Skin Analyzer CS50 (Inforward Inc., Japan) at baseline and 4 weeks after the final treatment session. RESULTS: Significant reduction in the mean area of periorbital wrinkles was detected at 1-month follow-up (80.64±28.96 mm2) compared to baseline (95.08±31.93 mm2). The improvement ratio of the wrinkle area was 15.19%. Pain during procedure seemed to be tolerable without any local anesthesia for all patients. Transient mild erythema was the only side effect reported during the study. CONCLUSION: In conclusion, MRF could still be an attractive modality for Korean patients with periorbital wrinkles if the treatment is conducted repeatedly with sufficient energy and proper intervals.

9.
J Dermatol ; 45(5): 546-553, 2018 May.
Article in English | MEDLINE | ID: mdl-29574999

ABSTRACT

Rosacea is a common chronic inflammatory skin condition. Although several epidemiological and etiologic studies with large sample sizes have been conducted on Caucasians, such data regarding Asian populations are lacking. A total of 580 patients diagnosed with rosacea were enrolled from October 2014 to February 2015 at 14 general hospitals. Questionnaires, including the standard classification and grading system, were used for evaluation. The average age of the patients was 47.9 years. While 83.8% of patients revealed a single subtype, 16.2% of patients revealed mixed subtypes showing two or more subtypes simultaneously. Erythematotelangiectatic rosacea (ETR) was the most prevalent subtype. ETR combined with papulopustular rosacea showed the highest proportion in the mixed subtype group. Mild severity was revealed in 71.9% of patients. The most common aggravating factor was emotional changes (51.7%), followed by stress (48.4%). Approximately half of the patients (47.4%) showed relatively low awareness of rosacea. By identifying the epidemiological and etiologic features in Korea, we can suggest valuable clinical avenues for research, education and awareness among rosacea patients.


Subject(s)
Health Knowledge, Attitudes, Practice , Rosacea/epidemiology , Adolescent , Adult , Aged , Child , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Patient Education as Topic , Prevalence , Republic of Korea/epidemiology , Rosacea/pathology , Severity of Illness Index , Skin/pathology , Surveys and Questionnaires , Young Adult
10.
Indian J Dermatol Venereol Leprol ; 84(2): 148-152, 2018.
Article in English | MEDLINE | ID: mdl-29376509

ABSTRACT

BACKGROUND: Immunoglobulin E (IgE) plays an important role in allergic diseases. Although several studies have shown the association of serum total IgE and allergen-specific IgE levels with allergic dermatological diseases such as atopic dermatitis, there are few studies addressing this association for skin diseases in general. AIMS: We sought to evaluate IgE levels in skin diseases and investigate the differences based on the disease type and clinical factors such as gender and age. METHODS: Data from 2836 patients who visited the dermatologic clinic of the Konkuk University Hospital, Seoul, Republic of Korea for 4 years were reviewed to document IgE levels and clinical information. IgE levels were collated with the type of skin disease, gender, and age. RESULTS: Patients with atopic dermatitis had a much higher total IgE level and were more susceptible to allergens as compared to other disease groups. Patients in other disease groups showed no significant differences in IgE levels. Men showed higher total IgE levels but the gender differences decreased with increasing age. LIMITATIONS: The data were collected from patients at a referral centre and thus may not represent the general population of dermatologic patients. There was a lack of information regarding factors that could potentially influence IgE levels such as smoking history and disease severity. CONCLUSIONS: The results suggest that there are physiological or environmental differences in IgE-mediated immune responses between males and females. Also, except for atopic dermatitis, there were no clinical differences in the IgE levels among various skin diseases.


Subject(s)
Allergens/blood , Immunoglobulin E/blood , Skin Diseases/blood , Skin Diseases/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Female , Humans , Male , Middle Aged , Young Adult
11.
Exp Dermatol ; 27(4): 366-373, 2018 04.
Article in English | MEDLINE | ID: mdl-29356103

ABSTRACT

With the recent availability of culture-independent sequencing methods, studies have been conducted to analyse skin micro-organisms present in patients with atopic dermatitis (AD). However, the database on the skin fungal communities, "mycobiome," has been relatively restrictive compared with the bacterial world. We aimed to comparatively analyse the overall skin mycobiome between patients with AD and healthy individuals in the Korean population. We analysed skin swab samples obtained from the antecubital fossae of 8 patients with AD and 8 healthy controls. Using sequencing method followed by direct DNA extraction and molecular PCR, taxonomic compositions of fungi at stepwise level ranks were analysed. The phylogenic marker used was internal transcribed spacer 2 regions of DNA. We observed the tendency of higher intra- and interpersonal taxonomic diversity at genus and species levels in AD samples. Non-Malassezia fungal diversity was also noticeable in the patient group compared with healthy controls. Malassezia globosa and Malassezia restricta were prevalent in all samples across both study groups, and some Malassezia species, including Malassezia sloofiae and Malassezia dermatis, characterized AD. Our data might provide a new insight into the mycobiome of adult AD, which contributes to building a systemic mycobiome database in AD.


Subject(s)
DNA, Fungal/analysis , Dermatitis, Atopic/microbiology , Malassezia/isolation & purification , Mycobiome , Adolescent , Adult , Ascomycota/isolation & purification , Basidiomycota/isolation & purification , Biodiversity , Case-Control Studies , Female , Humans , Male , Republic of Korea , Young Adult
12.
Mol Med Rep ; 16(6): 9120-9124, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28990056

ABSTRACT

Arctiin, a lignin isolated from Arctium lappa, exhibits a variety of biological effects, including anti­viral, anti­inflammatory, and anti­proliferative actions, in mammalian cells. In a previous study, arctiin was demonstrated to induce procollagen type I synthesis and exhibited protective effects against ultraviolet B (UVB) radiation in normal human dermal fibroblasts (nHDFs). However, the underlying molecular mechanism of arctiin­mediated collagen synthesis remains unknown. In the present study, the mechanism for increased expression of collagen type 1α 1 chain (COL1A1) mRNA in arctiin­induced nHDFs was identified. The expression of microRNA­378b (miR­378b), downregulated by arctiin, was correlated with the expression of sirtuin­6 (SIRT6) mRNA, a regulator of COL1A1 mRNA. Furthermore, it was revealed that arctiin protected the UVB radiation­mediated decrease in COL1A1 mRNA expression, through the miR­378b/SIRT6 signaling pathway. In conclusion, these results suggest that arctiin regulates COL1A1 through the miR­378b­SIRT6 axis.


Subject(s)
Collagen Type I/metabolism , Fibroblasts/drug effects , Fibroblasts/metabolism , Furans/pharmacology , Gene Expression Regulation/drug effects , Glucosides/pharmacology , MicroRNAs/genetics , RNA, Messenger/genetics , Sirtuins/genetics , Cell Survival , Cells, Cultured , Collagen Type I, alpha 1 Chain , Dermis/cytology , Gene Expression Regulation/radiation effects , Humans , Plant Extracts/pharmacology , RNA Interference , Ultraviolet Rays
13.
Mol Med Rep ; 16(6): 8520-8524, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28983623

ABSTRACT

Ultraviolet (UV) light mediates skin aging and induces destruction of the dermis by modulating the expression levels of extracellular matrix­associated genes, including collagen and matrix metalloproteinases. Sirtuin 6 (SIRT6), a member of the sirtuin family of proteins, regulates collagen metabolism and is an established anti­aging protein. However, the exact underlying mechanism by which SIRT6 expression is regulated in dermal fibroblasts during the aging process is unclear. The present study demonstrated that expression of microRNA­378b (miR­378b) is induced in UVB­exposed human dermal fibroblasts (HDFs), and this was inversely associated with the mRNA expression levels of α­1­type 1 collagen (COL1A1). In addition, knockdown of miR­378b enhanced the mRNA expression levels of COL1A1 in HDFs. A target analysis for miR­378b was performed, and the results revealed that SIRT6, a regulator of COL1A1, contains a target sequence for miR­378b in its 3'untranslated region. Notably, the present study demonstrated that an miR­378b mimic and inhibitor may directly regulate SIRT6 expression in HDFs. In conclusion, the present study suggested that miR­378b represses the mRNA expression levels of COL1A1 via interference with SIRT6 in HDFs, and may contribute to the underlying molecular mechanism by which UVB inhibits collagen I in dermal fibroblasts.


Subject(s)
Collagen Type I/genetics , Gene Expression Regulation/radiation effects , MicroRNAs/metabolism , RNA Interference , Sirtuins/metabolism , 3' Untranslated Regions/genetics , Collagen Type I/metabolism , Collagen Type I, alpha 1 Chain , Dermis/cytology , Down-Regulation/radiation effects , Fibroblasts/metabolism , Fibroblasts/radiation effects , Humans , MicroRNAs/genetics , Protein Binding/radiation effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sirtuins/genetics , Ultraviolet Rays
14.
Biosci Biotechnol Biochem ; 81(12): 2323-2329, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29032741

ABSTRACT

Dermal papilla (DP) is a pivotal part of hair follicle, and the smaller size of the DP is related with the hair loss. In this study, we investigated the effect of titrated extract of Centella asiatica (TECA) on hair growth inductive property on 3D spheroid cultured human DP cells (HDP cells). Significantly increased effect of TECA on cell viability was only shown in 3D sphered HPD cells, not in 2D cultured HDP cells. Also, TECA treatment increased the sphere size of HDP cells. The luciferase activity of STAT reporter genes and the expression of STAT-targeted genes, SOCS1 and SOCS3, were significantly decreased. Also, TECA treatment increased the expression of the hair growth-related signature genes in 3D sphered HDP cells. Furthermore, TECA led to downregulation of the level of phosphorylated STAT proteins in 3D sphered HDP cells. Overall, TECA activates the potential of hair inductive capacity in HDP cells.


Subject(s)
Centella/chemistry , Dermis/cytology , Hair/drug effects , Hair/growth & development , Plant Extracts/pharmacology , Signal Transduction/drug effects , Spheroids, Cellular/drug effects , Gene Expression Regulation/drug effects , Humans , Spheroids, Cellular/cytology , Spheroids, Cellular/metabolism
15.
Mol Med Rep ; 16(6): 9763-9769, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29039587

ABSTRACT

Hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) that induces numerous cellular events, including cellular senescence and inflammatory responses. Therefore, the aim of this study was to investigate the protective effect of Rosmarinic acid (RA) in H2O2­induced oxidative stress in normal human dermal fibroblasts (NHDFs). Cytotoxicity assays were performed using a water­soluble tetrazolium salt, and senescence­associated ß­galactosidase activity was determined to investigate the proportion of senescent cells. Antioxidant capacities were evaluated via H2O2­scavenging activity, reverse transcription­quantitative polymerase chain reaction, NRF2 luciferase reporter gene activity and intracellular ROS scavenging assays. Cytokine­coded gene expression analysis and nuclear factor­κB luciferase activity were determined to verify the anti­inflammatory effect of RA. As a result, the present study demonstrated that rosmarinic acid inhibited H2O2­induced oxidative stress and inflammatory responses in normal human dermal fibroblasts. Initially, the doses of RA that exerted minimal cytotoxic effects in NHDFs were determined using a cytotoxicity assay. Subsequently, pretreatment with the appropriate doses of RA significantly reversed the H2O2­induced decrease in NHDF cell viability and decreased cellular senescence of NHDFs. In addition, RA inhibited H2O2­induced ROS production in NHDFs, as determined by a ROS scavenging assay. The protective effects of RA were mediated by the inhibition of nuclear factor erythroid­derived 2­like 2, a transcription factor that functions as a key regulator of redox sensitivity. Furthermore, RA suppressed H2O2­induced inflammation in NHDFs and significantly rescued H2O2­induced downregulation of sirtuin 1. RA also inhibited nuclear factor (NF)­κB transcriptional activity and the expression of NF­κB target genes, including tumor necrosis factor­α and interleukin­6, in H2O2­exposed NHDFs. Taken together, these data indicate that RA inhibits H2O2­induced cellular damage in NHDFs.


Subject(s)
Cellular Senescence/drug effects , Cinnamates/pharmacology , Depsides/pharmacology , Dermis/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Hydrogen Peroxide/pharmacology , Serine Proteinase Inhibitors/pharmacology , Animals , Biomarkers , Cell Survival/drug effects , Cells, Cultured , Gene Expression , Genes, Reporter , Humans , Mice , NF-kappa B/metabolism , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Rosmarinic Acid
16.
Ann Dermatol ; 29(3): 321-326, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28566909

ABSTRACT

BACKGROUND: A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options. OBJECTIVE: The aim of this study was to obtain in vitro susceptibility profiles of Malassezia restricta and M. globosa, the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos. METHODS: Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml. RESULTS: Castanea crenata shell, Camellia sinensis leaf, and oil-soluble Glycyrrhiza extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The C. crenata shell and oil-soluble Glycyrrhiza extracts demonstrated especially high anti-Malassezia activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, Cryptococcus and Candida. CONCLUSION: C. crenata shell and oil-soluble Glycyrrhiza extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.

17.
J Photochem Photobiol B ; 173: 196-203, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28595074

ABSTRACT

Ultraviolet (UV) light exposure causes skin photoaging, which is known to be preventable and controllable by application of UV-protective agents. In this study, we demonstrated, for the first time, that the extract of microalgae Arthrospira platensis has a reverse effect on UV-induced photodamage such as loss of cell viability, cellular senescence, DNA damage, and collagen destruction in dermal fibroblasts. Forty-eight extracts were prepared from the cell biomass by controlling culture light conditions, extract solvents, and disruption methods. Then, we analyzed their cytotoxicities using WST-1 assay and separated low and high cytotoxic extracts with normal human dermal fibroblasts (nHDFs). Using the low cytotoxic extracts, we performed UVB protection assay and selected the most effective extract demonstrating protective effect against UVB-induced nHDF damage. Flow cytometric analysis and senescence-associated (SA) ß-galactosidase assay showed that pretreatment with the extract reversed UVB-induced G2/M phase cell cycle arrest and senescence in nHDFs. Furthermore, UVB-induced DNA damage in nHDFs, such as cyclobutane pyrimidine dimer formation, was significantly suppressed by the extract. Further, quantitative real-time PCR experiments revealed that the extract significantly inhibited UVB-induced upregulation of matrix metalloproteinase 1 (MMP1) and MMP3 expression in nHDFs. Therefore, we concluded that the microalgae extract can be a potential anti-photoaging agent.


Subject(s)
Cellular Senescence/radiation effects , DNA Damage/drug effects , Matrix Metalloproteinase 1/metabolism , Plant Extracts/chemistry , Protective Agents/pharmacology , Spirulina/chemistry , Ultraviolet Rays , Cell Survival/drug effects , Cell Survival/radiation effects , Cells, Cultured , Cellular Senescence/drug effects , DNA Damage/radiation effects , Dermis/cytology , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , G2 Phase Cell Cycle Checkpoints/drug effects , G2 Phase Cell Cycle Checkpoints/radiation effects , Humans , M Phase Cell Cycle Checkpoints/drug effects , M Phase Cell Cycle Checkpoints/radiation effects , Matrix Metalloproteinase 1/genetics , Plant Extracts/pharmacology , Protective Agents/chemistry , Pyrimidine Dimers/radiation effects , Spirulina/metabolism , Up-Regulation/drug effects
18.
J Dermatol Sci ; 88(1): 29-35, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28592369

ABSTRACT

BACKGROUND: Previous studies have shown the expression of histamine H4 receptor (H4R) on CD4+ T cells, especially human CD4+ Th2-polarized T cells. OBJECTIVE: This study aimed to investigate the role of H4R on these effector T cells in psoriasis. METHODS: We enrolled three patients each with active psoriasis, inactive psoriasis, scalp seborrheic dermatitis, and three normal controls, and compared the basal expression of H4R mRNA in their peripheral blood CD4+ T cells. Then, we identified H4R expression in dermal CD4+ T cells. Furthermore, we investigated H4R expression after stimulating separated peripheral blood CD4+ T cells with several inflammatory cytokines. RESULTS: The results showed higher H4R expression in the active psoriasis group compared to the inactive psoriasis group. It was interesting that interleukin (IL)-23, which is a representative cytokine contributing to Th17 cell differentiation, stimulated H4R expression significantly. After adding a selective H4R antagonist (JNJ-7777120) while the CD4+ T cells were polarized into Th17 cells, we observed a tendency toward suppressed IL-17 secretion. CONCLUSIONS: Histamine stimulation influences the IL-17 pathway in psoriasis via the fourth histamine receptor subtype, H4R, on CD4+ T cells. The immunomodulatory roles of H4R suggest its potency as a new therapeutic target for obstinate psoriasis.


Subject(s)
Histamine/immunology , Interleukin-17/immunology , Psoriasis/immunology , Receptors, Histamine H4/immunology , Th17 Cells/immunology , Cell Separation , Dermatitis, Seborrheic/blood , Dermatitis, Seborrheic/immunology , Dermatitis, Seborrheic/pathology , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Histamine/metabolism , Humans , Indoles/pharmacology , Interleukin-17/metabolism , Interleukin-23/immunology , Interleukin-23/metabolism , Piperazines/pharmacology , Psoriasis/blood , Psoriasis/pathology , Receptors, Histamine H4/antagonists & inhibitors , Receptors, Histamine H4/metabolism , Recombinant Proteins/metabolism , Signal Transduction/immunology , Th17 Cells/metabolism
19.
Microbiol Immunol ; 61(7): 258-263, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28593634

ABSTRACT

A Rickettsia sp. was isolated from the blood of a patient with an acute febrile illness using the shell vial technique; the isolate was named CN45Kr and was identified by molecular assay as Rickettsia monacensis, which was first recognized as a pathogen in Spain. Sequencing analysis showed that the gltA sequence of the isolate was identical to that of Rickettsia sp. IRS3. The ompA-5mp fragment sequence showed 100% identity to those of R. monacensis and Rickettsia sp. In56 and ompA-3pA In56 and 100% identity to that of Rickettsia sp. IRS3. The ompB sequence was found to have 99.9% similarity to that of R. monacensis IrR/Munich. This study confirms the pathogenicity of this agent and provides additional information about its geographic distribution.


Subject(s)
Rickettsia Infections/microbiology , Rickettsia/isolation & purification , Aged , Animals , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Genes, Bacterial/genetics , Humans , Male , Mice , Phylogeny , Republic of Korea , Rickettsia/classification , Rickettsia/genetics , Rickettsia Infections/blood , Rickettsia Infections/diagnosis , Sequence Analysis, DNA
20.
Ann Dermatol ; 29(2): 206-209, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28392649

ABSTRACT

Drug reaction with eosinophilia and systemic symptom (DRESS) syndrome is a type of severe adverse drug-induced reaction. Dermatologists should make a quick diagnosis and provide appropriate treatment for DRESS syndrome to reduce mortality rates, which can be as high as 10%. We present the case of a 47-year-old man with schizoaffective disorder treated with lamotrigine who developed DRESS syndrome to emphasize the importance of close observation of patients with drug eruption. He was consulted for erythematous maculopapular rashes on the trunk that developed 3 weeks after starting lamotrigine. A few days later, he developed generalized influenza-like symptoms. The skin rashes spread over his entire body, and the sense of itching was rapidly aggravated within a few days. Increased liver enzyme levels and significant eosinophilia were found on laboratory test results. His condition was diagnosed as DRESS syndrome, and he was treated with systemic and topical corticosteroids for 2 weeks.

SELECTION OF CITATIONS
SEARCH DETAIL
...